---
title: "单细胞测序+基因signature，8+套路收入囊中！"
date: 2022-10-12T00:32:16Z
draft: ["false"]
tags: [
  "fetched",
  "挑圈联靠"
]
categories: ["Acdemic"]
---
单细胞测序+基因signature，8+套路收入囊中！ by 挑圈联靠
------
<div><section data-mpa-powered-by="yiban.io"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><p data-mid=""><span><strong>一、研究背景</strong></span></p></section></section></section></section></section><section><strong><span>基因signature</span></strong><span><span>是</span><span><strong>生信高分文章</strong></span></span><span>主要套路之一。</span></section><section><strong><span>单细胞基因signature</span></strong><span>结合公共数据挖掘，随随便便就是</span><strong><span>CNS！</span></strong></section><section><span>除了CNS，无论是冲</span><strong><span>15到20的高分</span></strong><span>，还是入门小白想拿个</span><strong><span><span>8</span><span>+</span></span></strong><span>，任何需求都可以轻松满足！</span></section><section><strong><span>套路也非常简单，</span></strong><span><strong>原有的公共数据挖掘加个单细胞锦上添花就好了。</strong></span></section><p><span><strong><span><strong><span>单细胞基因signature套路</span></strong><br></span></strong></span></p><p><span><strong><span>扫码立即咨询</span></strong></span></p><section><img data-ratio="1.0852713178294573" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/OOT9X8luDTDf7hovU2syMiaIpW48jD6Xxj73hdoBHz0miaMibHKIUJjtkZTxic3shWIaPicRhZr5KBa0eqUOd1zHdHg/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-type="png" data-w="129" src="https://mmbiz.qpic.cn/sz_mmbiz_png/OOT9X8luDTDf7hovU2syMiaIpW48jD6Xxj73hdoBHz0miaMibHKIUJjtkZTxic3shWIaPicRhZr5KBa0eqUOd1zHdHg/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></section><section><span>下面我们就去Pubmed里看看。</span></section><section><span>输入检索式“</span><span><strong>(gene signature) AND (single cell sequencing)</strong></span><span>”，可以检索到6807条结果，其中今年已发表的有522篇，</span></section><section><span>相关</span><span><strong>文章数量近几年直线上升,今年还未结束，预计可以达到和去年大致持平的水平。该领域已成为稳定的热门领域，发文还是比较有保证的。</strong></span></section><section><span>下面我们看一下影响因子，先根据</span><span><strong>相关性</strong></span><span><span>排序，随手一搜就是</span><span><strong>CNS！发文巅峰！</strong></span></span><strong></strong></section><p><img data-ratio="0.86171875" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrR8ZRFrmbycoH2s70x1VHvrcCprjw48GF5PP8BTzG4JbHCLeia6q2yuFA/640?wx_fmt=png" data-type="png" data-w="1280" src="https://mmbiz.qpic.cn/sz_mmbiz_png/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrR8ZRFrmbycoH2s70x1VHvrcCprjw48GF5PP8BTzG4JbHCLeia6q2yuFA/640?wx_fmt=png"></p><p><img data-ratio="0.8283582089552238" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrRcVSYiajMLjdS5Ul8xKMibx9TPBMv6UmFwCY3emhOicxaylBVl0vZTmOYA/640?wx_fmt=png" data-type="png" data-w="938" src="https://mmbiz.qpic.cn/sz_mmbiz_png/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrRcVSYiajMLjdS5Ul8xKMibx9TPBMv6UmFwCY3emhOicxaylBVl0vZTmOYA/640?wx_fmt=png"></p><section><span>接下来根据</span><span><strong>发表时间</strong></span><span>排序，</span><strong><span>15+</span></strong><span>的高分和</span><strong><span>8+</span></strong><span>的小白文应有尽有！</span></section><p><img data-ratio="0.9671875" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrRJ719ib6uLJx4Vg8WI6SyZWMzWPibeNhmrvibdQfeicwz7Dia7zCyibjmR4Ew/640?wx_fmt=png" data-type="png" data-w="1280" src="https://mmbiz.qpic.cn/sz_mmbiz_png/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrRJ719ib6uLJx4Vg8WI6SyZWMzWPibeNhmrvibdQfeicwz7Dia7zCyibjmR4Ew/640?wx_fmt=png"></p><p><img data-ratio="1.0212765957446808" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrR87pFZ7BbW5b1XxdSzGoQANROoue5icmQWnk4TznKJYvwOxDvtMySaBg/640?wx_fmt=png" data-type="png" data-w="940" src="https://mmbiz.qpic.cn/sz_mmbiz_png/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrR87pFZ7BbW5b1XxdSzGoQANROoue5icmQWnk4TznKJYvwOxDvtMySaBg/640?wx_fmt=png"></p><section><span>做单细胞结合公共数据挖掘，一般也会配套做bulk seq，也是一样的场面。</span><br></section><p><img data-ratio="1.0078125" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrRwvmCADrxUriay3VA9JWicjsCFiadsBfqQ37jWY7u5rcibD0kibQGicBiaic32w/640?wx_fmt=png" data-type="png" data-w="1280" src="https://mmbiz.qpic.cn/sz_mmbiz_png/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrRwvmCADrxUriay3VA9JWicjsCFiadsBfqQ37jWY7u5rcibD0kibQGicBiaic32w/640?wx_fmt=png"></p><section><br></section><section><span>很让人心动了！</span></section><section><span>套路也还是</span><strong><span>老样子</span></strong><span>：</span><strong><span>筛表型分子</span></strong><span>!</span></section><section><span>接下来，我们就从几篇<strong>8+</strong>文献，依据“</span><span><strong><span>挑圈联靠</span></strong></span><span>“思维，对研究套路做一下解读。</span></section><section><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><p data-mid=""><span><strong>二、数据集</strong></span></p></section></section></section></section></section><p><span>GEO单细胞数据集</span></p><p><span>Bulk seq转录组数据集：TCGA+GEO</span></p><section><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><p data-mid=""><span><strong>三、技术路线</strong></span></p></section></section></section></section></section><p><br></p><p><img data-ratio="0.54765625" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrRQQhopWYwjAZib1Js7ibLZpgL1CsMV2kUSguaM7n3mbrA4ftzjpcDichFA/640?wx_fmt=jpeg" data-type="jpeg" data-w="1280" src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrRQQhopWYwjAZib1Js7ibLZpgL1CsMV2kUSguaM7n3mbrA4ftzjpcDichFA/640?wx_fmt=jpeg"></p><p><span><br></span></p><section><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><section data-mid="" mpa-from-tpl="t"><p data-mid=""><span><strong>四、分析内容</strong></span></p></section></section></section></section></section><p><strong><span>1、不同细胞亚群的识别（挑、圈）</span></strong></p><p><img data-ratio="0.740625" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrRdicojmbMcOkBRLvjBaG4AScpLSFibPV6upm5J3ia7HtjaBbTgzsnxbYVA/640?wx_fmt=jpeg" data-type="jpeg" data-w="1280" src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrRdicojmbMcOkBRLvjBaG4AScpLSFibPV6upm5J3ia7HtjaBbTgzsnxbYVA/640?wx_fmt=jpeg"></p><p><span>在所有病变中对恶性细胞</span><strong><span>降维作UMAP图</span></strong><span>，按集群进行着色和标记。条形图显示按照治疗史分组的集群比例。将不同类细胞</span><strong><span>分门别类</span></strong><span>，也就是</span><strong><span>“圈”</span></strong><span>(A)。</span></p><p><span>再</span><span><strong>“挑”</strong></span><span>，确定集群定义基因的比例归一化表达的</span><span><strong>热图</strong></span><span>。(B) </span></p><p><span>得到差异后，再</span><span><strong><span>“圈”</span></strong></span><span>，做</span><strong><span>富集分析</span></strong></p><p><span>比较两个优势恶性细胞簇之间的</span><span><strong>单细胞signature得分</strong></span><span>分布的小提琴图和波谱图，按活检部位划分。同时展示</span><strong><span>差异性标志物富集的显著性</span></strong><span>。<span>(C)</span></span></p><p><span>再做不同患者不同治疗方案的</span><span><strong>GSEA富集分析</strong></span><span>。<span>(D)</span></span></p><p><span>做差异表达q值热图，比较不同治疗方案患者的每个簇内细胞。<span>(E）</span></span></p><p><span>比较不同治疗方案患者</span><strong><span>每个簇内细胞差异表达</span></strong><span>q值热图。<span>(F) </span></span></p><p><span><strong><span>2、差异分析、聚类、富集（挑、圈）</span></strong></span></p><p><span>这一部分讨论</span><span><strong>免疫细胞</strong></span><span>的</span><strong><span>细胞状态特征</span></strong><span>。</span></p><p><span>(A-C)免疫</span><span><strong>细胞</strong></span><span>在GEO数据集中的</span><span><strong>表达分布</strong></span><span>。</span></p><p><span>(D-E) 免疫细胞状态的</span><strong><span>UMAP图</span></strong><span>，用颜色编码的CX3CR1和TOP2A的表达水平。(</span><strong><span>t-SNE，降维、聚类</span></strong><span>）</span></p><p><span>(F) 干扰素基因在七个</span><strong><span>集群</span></strong><span>中的</span><span><strong>差异性表达</strong></span><span>。</span></p><p><span>(G) 给定状态中</span><strong><span>差异表达基因</span></strong><span>的</span><span><strong>功能富集分析</strong></span><span>。</span></p><p><img data-height="1242" data-ratio="0.9794952681388013" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrRBDgkhicjwibUlrTicBoV3kp52ln9tl64rg9icVOF6FLrJ1J7G4hiaJPxaeA/640?wx_fmt=png" data-type="png" data-w="1268" data-width="1268" src="https://mmbiz.qpic.cn/sz_mmbiz_png/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrRBDgkhicjwibUlrTicBoV3kp52ln9tl64rg9icVOF6FLrJ1J7G4hiaJPxaeA/640?wx_fmt=png"></p><p><strong><span>3、signature的筛选和验证</span></strong></p><p><span>(A) 筛选signature的标准</span></p><p><span>(B）</span><span><strong>热图</strong></span><span>显示单细胞中TRS的</span><span><strong>表达</strong></span><span>。</span></p><p><span>(C）（左图）富集<span>signature</span>的</span><span><strong>GO</strong></span><span> term。(右图) 每个GO term涉及的基因(富集分析）</span></p><p><span>(D) </span><span><strong>肿瘤反应性T细胞组（红色）和其他T细胞组的signature分数的分布。（肿瘤-非肿瘤差异表达）</strong></span></p><p><span>(E）</span><strong><span>其他癌种</span></strong><span>的scRNA-seq数据集中T细胞状态的</span><strong><span>signature分数分布</span></strong><span>。</span><span>（其他癌，</span><strong><span>差异表达验证</span></strong><span>）</span></p><p><span>(F) <strong><span>signature分数</span></strong>与公共数据库</span><strong><span>肿瘤样本中</span></strong><span><strong>T细胞浸润比例的Spearman相关性。（相关性分析）</strong></span></p><p><img data-height="1639" data-ratio="0.8162350597609562" data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrREBnxvfIVNxsZeIc0hgaZvVJd7OFcR6uJn0e1dAMrClricu1v5rAfoicA/640?wx_fmt=jpeg" data-type="jpeg" data-w="2008" data-width="2008" src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrREBnxvfIVNxsZeIc0hgaZvVJd7OFcR6uJn0e1dAMrClricu1v5rAfoicA/640?wx_fmt=jpeg"></p><p><strong><span>4、两种模型对患者TMB影响、突变情况展示（挑、圈）</span></strong></p><p><span>与肿瘤反应性相关的富集途径和基因组畸变的综合特征。</span></p><p><span>(A）TCGA队列中<span>signature</span>的表达水平进行主成分分析。条形图显示患者的<span>signature</span>分数。</span></p><p><span>(B）<strong>火山图显示TCGA队列中高组和低组之间差异表达的基因</strong>。效应分子用蓝色标示，趋化因子用绿色标示。</span></p><p><span>(C) 条形图显示富含明显上调基因的功能基因组。</span></p><p><span>(D, E）在低组（D）和高组（E）中显示了前20个</span><span><strong>最频繁突变的基因</strong></span><span>。(F) 显示了两组之间</span><span><strong>有明显差异的突变基因</strong></span><span>。</span></p><p><span>(G) Boxplots显示高组和低组之间对数转换的</span><span><strong>肿瘤突变负担（TMB）</strong></span><span>的差异。(H) Boxplots显示高组和低组之间的肿瘤内异质性、伤口愈合、同源重组缺陷和Th17细胞得分的差异。</span></p><p><img data-height="1956" data-ratio="1.0884808013355594" data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrR38mDXcjM7KibJ7MPiabKNcnl4QO0urVPuejPbrZhtEFPIAMGtias09icFg/640?wx_fmt=jpeg" data-type="jpeg" data-w="1797" data-width="1797" src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrR38mDXcjM7KibJ7MPiabKNcnl4QO0urVPuejPbrZhtEFPIAMGtias09icFg/640?wx_fmt=jpeg"></p><p><strong><span>5、肿瘤细胞与间配体相互作用（联）</span></strong></p><p><span><strong><span>肿瘤细胞与免疫细胞的相互作用</span></strong></span><span>，也就是“联”，也是研究者们关注的热点之一。</span></p><p><span><strong><span>肿瘤细胞</span></strong></span><span>表达了相对高水平的趋化因子和与抗原呈递和TGF-beta信号通路</span><span><strong>相关的配体</strong></span><span>，而</span><span><strong>相</strong></span><strong><span>应的受体</span></strong><span>在免疫细胞中广泛表达，表明这些配体在影响</span><strong><span>肿瘤的免疫细胞浸润</span></strong><span>方面起着重要作用（A）。</span></p><p><span>相反，配体及其相关的促炎症细胞因子，以及与肿瘤坏死因子家族和细胞毒性有关的配体在免疫细胞中表达，也表明</span><strong><span>免疫细胞对肿瘤细胞有杀伤力</span></strong><span>（图3A）。</span></p><p><span>(B）展示了当肿瘤细胞作为发送者时，肿瘤细胞和CD8+T免疫细胞之间的重要</span><strong><span>配体-受体对</span></strong><span>的数量。每个链接都由肿瘤细胞状态着色，链接厚度代表重要的配体-受体对的数量。</span></p><p><span>(C）则相反，展示了当免疫细胞作为发送者时，肿瘤细胞和免疫细胞之间的重要配体-受体对的数量。每个环节都由免疫细胞的状态来着色。</span></p><p><img data-ratio="1.142063492063492" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrR4p6KialTKmK1uqGP105fho0WRGe6RBGNklJiboDAvHNib4TyG5oWBB15w/640?wx_fmt=jpeg" data-type="jpeg" data-w="1260" src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrR4p6KialTKmK1uqGP105fho0WRGe6RBGNklJiboDAvHNib4TyG5oWBB15w/640?wx_fmt=jpeg"></p><p><strong><span>6、预后评估（靠）</span></strong></p><p><span>肿瘤中signature的预后评估。</span></p><p><span>(A) </span><span><strong>KM生存曲线</strong></span><span>显示，在TCGA-SKCM队列中，根据TRS评分的中位数对患者进行分层，</span><span><strong><span>生存概率</span></strong></span><span>有明显差异<strong>。</strong></span></p><p><span>(B) 细化TRS的KM生存曲线分析。</span></p><p><span>(C) 森林图显示，在TCGA队列中，调整免疫细胞的浸润水平和临床特征后，TRS评分的独立预后价值。</span></p><p><span>(D) KM生存曲线显示</span><strong><span>signature与肿瘤患者的总生存期有明显关联</span></strong><span>。</span></p><p><span>(E-H）比较<span>signature</span>与免疫细胞浸润和已发表的肿瘤预后相关signature在患者分层（E）、时间依赖性AUC（F）、C-指数（G）和高风险组与低风险组之间限制性平均生存时间（RMST）比率方面的预后表现（H）。</span></p><p><span>E）中的颜色表示</span><strong><span>单变量Cox比例危险回归分析</span></strong><span>中特征的危险比，*表示根据相应的特征在生存概率方面对黑色素瘤患者进行的显著分层。</span></p><p><img data-height="1867" data-ratio="1.039532293986637" data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrRA0aJckacO2gxibUUPQ7CUagFRJRSuwUWTSiabN7ticr3FM4VM4SWVr48A/640?wx_fmt=jpeg" data-type="jpeg" data-w="1796" data-width="1796" src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/OOT9X8luDTBcZsiaicgl4bjrMJiappFlnrRA0aJckacO2gxibUUPQ7CUagFRJRSuwUWTSiabN7ticr3FM4VM4SWVr48A/640?wx_fmt=jpeg"></p><section><span>发文影响因子高，愿意努力的小伙伴也可以冲顶级期刊！但分析内容都是很常规的，很简单的。</span></section><section><span>小伙伴们有没有很心动呢？</span><br></section><section><span><strong><span>这样的成功很好复制！</span></strong></span><br></section><section><span><strong>我们为大家精心准备了</strong></span><span><strong>彩蛋</strong></span><span><strong>环节！</strong></span></section><section><span>基因signature能做的当然不止这些！</span></section><section><strong><span>挑圈联靠</span></strong><span>能搞定的套路也不止这点！<br></span></section><section><span>在我们</span><span><strong>挑圈联靠</strong></span><span>，除了以上这些代表性</span><span><strong>生信分析服务</strong></span><span>项目，</span></section><section><span>还有</span><span><strong><span>更多</span></strong></span><span>分析项目帮助小伙伴们冲击更高分的文章！欲知详情，请戳我们技术销售的微信详细了解！<br></span></section><p><span><strong><span>公共数据挖掘<br></span></strong></span></p><p><span><strong><span>个性化分析扫码咨询</span></strong></span></p><p><img data-ratio="1.0852713178294573" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/OOT9X8luDTDf7hovU2syMiaIpW48jD6Xxj73hdoBHz0miaMibHKIUJjtkZTxic3shWIaPicRhZr5KBa0eqUOd1zHdHg/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-type="png" data-w="129" src="https://mmbiz.qpic.cn/sz_mmbiz_png/OOT9X8luDTDf7hovU2syMiaIpW48jD6Xxj73hdoBHz0miaMibHKIUJjtkZTxic3shWIaPicRhZr5KBa0eqUOd1zHdHg/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></p><p><span>参考文献：</span></p><p><span>1、Single-Cell Transcriptomic Analysis Reveals the Crosstalk Propensity Between the Tumor Intermediate State and the CD8+ T Exhausted State to be Associated with Clinical Benefits in Melanoma, Frontiers in Immunology. 2022 </span><span>IF：8.79</span></p><p><span>2、Single-Cell Transcriptomic Analysis Reveals a Tumor-Reactive T Cell Signature Associated With Clinical Outcome and Immunotherapy Response In Melanoma, Frontiers in Immunology. 2022 </span><span>IF：8.79</span></p><p><span>3、Identification of clinical prognostic features of esophageal cancer based on m6A regulators. Frontiers in Immunology. 2022 </span><span>IF：8.79</span></p><p><span>4、Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma. Cancer Cell. 2021 </span><span>IF：38.59</span></p><p><span><br></span></p><section><img data-croporisrc="https://mmbiz.qlogo.cn/sz_mmbiz_png/OOT9X8luDTDbwOcNic7TNTbibA9obe0MCjMx4ictjcp1ZZjxYvAPmAlu25FsuKYUeuWSpjEGBmm5mLgW0rqErlTlQ/0?wx_fmt=png" data-cropx1="0" data-cropx2="206" data-cropy1="9" data-cropy2="189" data-ratio="0.8689320388349514" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/OOT9X8luDTDbwOcNic7TNTbibA9obe0MCjaqK8OziaHP6xIvLg9ibbd5CcChAhqSGmxWzW39KOYwpJzVMEPribVaD0Q/640?wx_fmt=jpeg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-type="jpeg" data-w="206" src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/OOT9X8luDTDbwOcNic7TNTbibA9obe0MCjaqK8OziaHP6xIvLg9ibbd5CcChAhqSGmxWzW39KOYwpJzVMEPribVaD0Q/640?wx_fmt=jpeg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></section><p>—<span data-brushtype="text">END</span>—<br></p><p><br></p><p><span>撰文丨<span>三叶虫</span></span></p><p><span>排版</span><span>丨<span>三叶虫</span></span></p><p><span>编辑</span><span>丨<span>三叶虫</span></span></p><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/obJtA8vgV84IzNlxNXqgyw",target="_blank" rel="noopener noreferrer">原文链接</a>
